Learning hub
Scientific and Clinical Updates
Explore a comprehensive collection of educational resources designed to enhance your understanding and management of various type 2 inflammatory diseases.
Each learning hub page functions as a centralized repository of information for a specific therapeutic area, meticulously organized by key topics relevant to your clinical practice, such as pathophysiology, burden of disease, and disease management strategies. Delve into the underlying mechanisms, assess the clinical impact, and review current best practices for patient care.
To support learning and self-assessment, each hub includes a quiz section, allowing you to gauge your understanding of the key concepts and principles.
Begin by selecting your area of interest below.
Learning Hub
Type 2 asthma is a common phenotype of asthma, characterized by key cytokines IL-4, IL-13, and IL-5, as well as elevated type 2 inflammatory biomarkers as FeNO, and eosinophils, or the need for maintenance OCS. Type 2 inflammation is evident in up to 88% of patients with severe asthma, representing a substantial portion of the disease burden associated with asthma. Explore the resources below better understand the role of type 2 inflammation in asthma.
Atopic dermatitis (AD) is a chronic, relapsing, systemic disease with a high impact on the lives of patients and caregivers that requires early intervention and long-term disease control. View resources below to learn more about a variety of topics related to AD.
